|
Elucidating the Function of the NF1 tumor suppressor and its effector pathways in
|
5R01CA111754-07
|
$284,401
|
$284,401
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
5R01CA129814-05
|
$318,505
|
$318,505
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Schwann Cells in Neurofibromatosis Type 2 (NF2)
|
5R01CA118032-05
|
$276,450
|
$276,450
|
RATNER, NANCY
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Role of gangliosides in tumor progression
|
3R01CA061010-16S1
|
$110,968
|
$83,226
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Role of gangliosides in tumor progression
|
4R01CA061010-16
|
$372,530
|
$279,398
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$114,493
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S1
|
$74,998
|
$2,250
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S2
|
$139,995
|
$4,200
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
$111,646
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Comprehensive Cancer Center Program at Fox Chase
|
2P30CA006927-48
|
$4,038,908
|
$121,167
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S1
|
$50,859
|
$1,526
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S2
|
$74,930
|
$2,248
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S3
|
$140,001
|
$4,200
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S4
|
$300,000
|
$9,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
|
5R01CA074177-14
|
$314,738
|
$314,738
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S1
|
$108,772
|
$2,175
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S2
|
$49,994
|
$1,000
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-13
|
$1,145,097
|
$22,902
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1
|
5R01CA142928-02
|
$395,129
|
$395,129
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-07
|
$331,162
|
$331,162
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
N/A
|
N01OD042139
|
$25,000
|
$8,250
|
UNKNOWN, UNKNOWN
|
NATIONAL ACADEMY OF SCIENCES:1108676
|
|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$371,010
|
N/A
|
National Cancer Institute
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$486,715
|
$486,714
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$486,715
|
$486,714
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
$89,109
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Protein Folding Mechanism
|
ZIA BC 010276
|
$285,604
|
$285,604
|
Bai, Yawen
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$261,870
|
$52,374
|
Bates, Susan
|
CCR (NCI)
|
|
Molecule-Guided Investigations into p53 Biology
|
ZIA BC 011261
|
$289,758
|
$57,951
|
Bernal, Federico
|
CCR (NCI)
|
|
Molecular Interactions that Drive p63 and p73 Function
|
ZIA BC 011376
|
$144,879
|
$28,975
|
Bernal, Federico
|
CCR (NCI)
|
|
Studies of Histone Functions in Chromatin; H2AX and DNA DSBs
|
ZIA BC 006140
|
$889,630
|
$44,481
|
Bonner, William
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$818,472
|
$572,930
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
$982,166
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,456,815
|
$545,681
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$489,703
|
$97,940
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$489,703
|
$171,396
|
Daar, Ira
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$641,770
|
$64,176
|
Dean, Michael
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$440,189
|
$22,009
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 010839
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target
|
ZIA BC 010840
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
Canine Glioma and Embryonic Neural Stem Cell Project
|
ZIA BC 011099
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor
|
ZIA BC 011100
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
|
ZIA BC 011101
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
The Role of miRNAs in Glioma Stem Cell and Glioma Biology
|
ZIA BC 011102
|
$536,416
|
$536,416
|
Fine, Howard
|
CCR (NCI)
|
|
The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data
|
ZIA SC 010100
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Animal Therapeutics Core
|
ZIC BC 011086
|
$804,624
|
$804,624
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,547,976
|
$2,547,976
|
Fine, Howard
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
$82,299
|
Gottesman, Michael
|
CCR (NCI)
|
|
Sensitization of chordoma cell lines to ionizing radiation
|
ZIA BC 011326
|
$198,518
|
$19,851
|
Haglund, Karl
|
CCR (NCI)
|
|
Role of Selenium in Development and Health
|
ZIA BC 005317
|
$286,567
|
$71,641
|
Hatfield, Dolph
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $32,061,943
|